Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9699829 | 0.98 | CPB2 (0.38) | CPB2OPRM1SLC7A5DNM1MEN1 | |
| SCHEMBL9699794 | 0.98 | CPB2 (0.38) | CPB2OPRM1SLC7A5DNM1MEN1 | |
| SCHEMBL9697278 | 0.98 | CPB2 (0.38) | CPB2OPRM1SLC7A5DNM1MEN1 | |
| SCHEMBL9698463 | 0.98 | CPB2 (0.38) | CPB2OPRM1SLC7A5DNM1MEN1 | |
| SCHEMBL9698407 | 0.84 | CPB2 (0.35) | CPB2OPRM1SLC7A5DNM1MEN1 | |
| SCHEMBL9698481 | 0.82 | CPB2 (0.38) | CPB2OPRM1SLC7A5DNM1MEN1 | |
| SCHEMBL9698452 | 0.82 | CPB2 (0.38) | CPB2OPRM1SLC7A5DNM1MEN1 | |
| SCHEMBL9698876 | 0.82 | CPB2 (0.38) | CPB2OPRM1SLC7A5DNM1MEN1 | |
| SCHEMBL9698440 | 0.82 | CPB2 (0.38) | CPB2OPRM1SLC7A5DNM1MEN1 | |
| SCHEMBL9697340 | 0.82 | CPB2 (0.36) | CPB2OPRM1SLC7A5DNM1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0498458-A2 | Novel aminoalkyl alkoxy silane compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-08-12 | — | — | EP | disclosed |